• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性Wistar/Furth肾母细胞瘤模型的生长特性

The growth characteristics of the metastatic Wistar/Furth Wilms' tumor model.

作者信息

Murphy G P, Williams P D, Klein R

出版信息

Res Commun Chem Pathol Pharmacol. 1975 Oct;12(2):397-404.

PMID:172997
Abstract

Growth characteristics, metastatic spread, and survival times were evaluated in a transplantable Wistar/Furth rat Wilms' tumor model. Tumor suspensions of various tumor cell dosages were injected in an attempt to find the optimum level of tumor take. Lung metastases were frequent following tumor injection by all routes. However, tumor spread to the lungs was the least frequent following subcutaneous (SC) injection of the tumor. Survival time for the intramuscular (IM) group was statistically longer at all tumor dose levels. For the 1 X 10(5) tumor dosage, survival time ranged from a mean of 27 days for the intrarenal (IR) group to a mean 42 days for the IM group. For the 1 X 10(4) dosage, survival time ranged from a mean of 37 days for the intraperitoneal (IP) group to a mean of 51 days for the IM group. It is concluded that this animal tumor closely resembles the human Wilms' tumor, and that the point at which the transplanted tumor fails to be successfully transplanted is below the dosage level of 1 X 10(3) tumor cells.

摘要

在可移植的Wistar/Furth大鼠肾母细胞瘤模型中评估生长特征、转移扩散和生存时间。注射不同肿瘤细胞剂量的肿瘤悬液,试图找到肿瘤接种的最佳水平。通过所有途径注射肿瘤后,肺转移都很常见。然而,皮下(SC)注射肿瘤后,肿瘤扩散到肺部的情况最少见。在所有肿瘤剂量水平下,肌肉注射(IM)组的生存时间在统计学上更长。对于1×10⁵的肿瘤剂量,肾内(IR)组的平均生存时间为27天,而IM组为42天。对于1×10⁴的剂量,腹腔内(IP)组的平均生存时间为37天,而IM组为51天。结论是,这种动物肿瘤与人类肾母细胞瘤非常相似,并且移植肿瘤未能成功移植的点低于1×10³肿瘤细胞的剂量水平。

相似文献

1
The growth characteristics of the metastatic Wistar/Furth Wilms' tumor model.转移性Wistar/Furth肾母细胞瘤模型的生长特性
Res Commun Chem Pathol Pharmacol. 1975 Oct;12(2):397-404.
2
Characterization of a Wilms' tumor model.一种肾母细胞瘤模型的特征描述。
Invest Urol. 1975 Jan;12(4):320-5.
3
The growth characteristics of metastases from experimental renal tumors.实验性肾肿瘤转移灶的生长特征
Res Commun Chem Pathol Pharmacol. 1976 Mar;13(3):541-50.
4
The effects of chemotherapy on the Wistar-Furth Wilms' Tumor.
J Med. 1975;6(5-6):401-10.
5
Effects of alpha-difluoromethylornithine on the growth of experimental Wilms' tumor and renal adenocarcinoma.α-二氟甲基鸟氨酸对实验性肾母细胞瘤和肾腺癌生长的影响。
Cancer Res. 1983 Sep;43(9):4031-4.
6
Erythropoietin levels in Wistar-Furth Wilms' tumor rats.Wistar-Furth肾母细胞瘤大鼠的促红细胞生成素水平
J Surg Oncol. 1976;8(2):131-5. doi: 10.1002/jso.2930080207.
7
Cell cultures derived from Wilms' tumour animal model.源自肾母细胞瘤动物模型的细胞培养物。
Anticancer Res. 1987 Jul-Aug;7(4B):717-9.
8
Study of platelet aggregation in vivo. IX. Effect of nafazatrom on in vivo platelet aggregation and spontaneous tumor metastasis.
J Med. 1982;13(1-2):35-47.
9
Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor.联合抗血管生成疗法:在肾母细胞瘤小鼠模型中疗效增强
J Pediatr Surg. 2001 Aug;36(8):1177-81. doi: 10.1053/jpsu.2001.25747.
10
[Experimental models of embryonic nephroblastomas (Wilms' tumor)].
Arkh Patol. 1980;42(2):44-51.

引用本文的文献

1
Paediatric genitourinary cancers and late effects of treatment.儿科泌尿生殖系统癌症及治疗的远期影响。
Nat Rev Urol. 2013 Jan;10(1):15-25. doi: 10.1038/nrurol.2012.218. Epub 2012 Nov 27.